Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

0.00

EX-DatePurpose
23 07 2021 Audited Results & A.G.M. Inter alia, to consider amongst other items: 1. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2020-21 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting.
14 08 2021 Quarterly Results
13 11 2021 Quarterly Results
14 02 2022 Quarterly Results
30 05 2022 Audited Results
13 08 2022 Quarterly Results
14 11 2022 Quarterly Results
14 02 2023 Quarterly Results
26 05 2023 Audited Results & A.G.M.
14 08 2023 Quarterly Results
10 11 2023 Quarterly Results
14 02 2024 Quarterly Results
14 11 2024 Quarterly Results
31 01 2025 Quarterly Results
30 05 2025 Audited Results
07 07 2025 Audited Results
23 07 2025 Inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st Extraordinary General Meeting and/or issue the corrigendum pertains to that item or matters related thereto.
14 08 2025 Quarterly Results
14 11 2025 Quarterly Results
03 12 2025 Buy Back of Shares

News

12-NOV-2025

Nectar Lifesciences completes sale of API and formulations business

The transfer is completed with effect from November 10, 2025

11:43 AM
08-JUL-2025

Nectar Lifesciences to sell API business and formulations for Rs 1,270 crore

This transaction forms a part of the company’s long-term strategy to streamline its operations, strengthen its financial position, and unlock value for shareholders

09:28 AM
11-MAR-2025

Nectar Lifesciences receives 7 observations for API manufacturing facility

The European regulator will conduct a re-inspection of the facility to verify the compliance and CAPA submitted which may lead to EuGMP approval

11:30 AM
Enrich money logo